RT Journal Article
SR Electronic
T1 Predicting Confrontation Naming in the Logopenic Variant of Primary Progressive Aphasia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.25.22276804
DO 10.1101/2022.06.25.22276804
A1 Jebahi, Fatima
A1 Nickels, Katlyn Victoria
A1 Kielar, Aneta
YR 2022
UL http://medrxiv.org/content/early/2022/06/28/2022.06.25.22276804.abstract
AB Naming difficulties are prominent and pervasive in the logopenic variant of primary progressive aphasia (lvPPA) and are related to its underlying deficits in phonological processing. Importantly, some words appear to be more vulnerable to deterioration than others. We hypothesize that these differences can be explained, in part, by words’ unique psycholinguistic properties. Our study investigated the role of psycholinguistic properties of words, along with their underlying psycholinguistic factors, on confrontation naming performance in individuals with lvPPA. Naming accuracy data were collected from 10 individuals with lvPPA using the Boston Naming Test (BNT). For each test item, values were extracted for frequency, contextual diversity, age of acquisition (AoA), word length, phonological neighborhood density (PND), concreteness, semantic neighborhood density (SND), familiarity, arousal, and valence. We examined the effects of these psycholinguistic properties on naming accuracy using logistic regression analyses at the individual level and multiple linear regression analysis at the group level. Age of acquisition emerged as the strongest psycholinguistic predictor of naming accuracy in lvPPA at both the individual and group levels. Given that AoA and frequency are highly correlated, mediation analyses were performed to identify the relationships between AoA, frequency, and naming accuracy. The influence of AoA on naming accuracy was only partially mediated by frequency. Principal component analysis was performed to extract fundamental factors of the psycholinguistic properties. Four principal psycholinguistic factors were extracted. These were interpreted as “lexical-semantic usage”, “phonological simplicity”, “semantic disembodiment”, and “semantic pleasantness”. These factor scores were entered into multiple linear and logistic regression analyses to investigate their relative contribution to naming accuracy in lvPPA. Results indicated that “lexical-semantic usage”, “semantic disembodiment”, and “semantic pleasantness” predicted naming performance at the group level. Additionally, “lexical-semantic usage” and “semantic disembodiment” emerged as significant predictors at the individual level. The effects of the psycholinguistic properties and their factors and their theoretical implications are discussed in the context of phonological deficits in lvPPA and models of word naming.Highlights:– Age of acquisition (AoA) predicts naming in lvPPA– The effect of AoA on naming corresponds with lvPPA’s phonological impairment– The effect of AoA on naming is mostly direct and partially mediated by frequency– PCA-extracted psycholinguistic factors independently predict naming in lvPPA– Factors related to lexical semantics, semantics, and emotionality affect namingCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Arizona Alzheimers Consortium and by BIO5 Institute at the University of Arizona to author AK.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board (IRB) at The University of Arizona gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors